A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
10/2006
10/12/2006	US20060229246 Peptide-enhanced transfections
10/12/2006	US20060228798 Homologous recombination in multipotent adult progenitor cells
10/12/2006	US20060228779 Method for producing factor G derived from horseshoe crab
10/12/2006	US20060228778 Novel vitamin D receptor related polypeptides, nucleic acid sequence encoding the same and uses thereof
10/12/2006	US20060228776 PINK-1 promoter
10/12/2006	US20060228420 Pharmaceutical compositions comprising microparticles for delivery into neurons
10/12/2006	US20060228414 Method for the preparation of controlled release formulations
10/12/2006	US20060228407 Enhanced delivery via serpin enzyme complex receptor
10/12/2006	US20060228406 Transfection reagent for non-adherent suspension cells
10/12/2006	US20060228404 Compositions and methods for treatment of hypertrophic tissues
10/12/2006	US20060228392 capable of enhancing the formation of osseous tissue in the animal in which it is implanted comprising a biocompatible matrix and a NELL-1 protein in an amount effective for stimulating a progenitor cell such that it is activated to differentiate into an osteoblast
10/12/2006	US20060228378 Also an antibody which specifically binds to the protein and a Hybridoma cell line that produces the protein; immunoprophylactic uses
10/12/2006	US20060228376 Virosome-like-particles
10/12/2006	US20060228375 Induction of mucosal immunity by vaccination via the skin route
10/12/2006	US20060228374 Oral DNA composition for hepatitis B virus chronic infection
10/12/2006	US20060228361 Dicer interacting proteins and uses therefor
10/12/2006	US20060228359 antibody; host cell; hybridoma;
10/12/2006	US20060228355 Camelidae single domain antibodies vhh directed against epidermal growth factor receptor and uses therefor
10/12/2006	US20060228344 Cell-containing preparations
10/12/2006	US20060228343 Cardiac glycoside resistant non-immunogenic selection marker
10/12/2006	US20060228342 Method for generating antigen-presenting cells
10/12/2006	US20060228341 Pleuripotent stem cells generated from adipose tissue-derived stromal cells and uses thereof
10/12/2006	US20060228336 Human prolyl isomerase 1 (PIN 1) promoter and uses thereof
10/12/2006	US20060228335 Rhesus carcino embryonic antigen, nucleotides encoding same, and uses thereof
10/12/2006	US20060228334 Modified adenoviral fiber with ablated to cellular receptors
10/12/2006	US20060228326 Active specific immunotherapy of cancer metastasis
10/12/2006	US20060228303 Method of screening for genes that influence pathological conditions or survival of animals infected with pathogen
10/12/2006	CA2603480A1 Use of an antibody against the laminin receptor or laminin receptor precursor for the treatment or diagnosis of several cancer types
10/12/2006	CA2603245A1 Hydrophilic dispersions of nanoparticles of inclusion complexes of amorphous compounds
10/11/2006	EP1710582A2 Suppressor genes
10/11/2006	EP1710307A2 RNA interference mediated inhibition of gene expression using short interfering nucleic acid (siNA)
10/11/2006	EP1710252A2 Flea head, nerve cord, hindgut and malpighian tubule nucleic acid molecules, proteins and uses thereof
10/11/2006	EP1709976A1 Emt- inducing agents
10/11/2006	EP1709973A1 Method of suppressing cancer
10/11/2006	EP1709972A1 Use of an antibody against the laminin receptor or laminin receptor precursor for the treatment or diagnosis of several cancer types
10/11/2006	EP1709194A2 DELIVERY OF DNA OR RNA VIA GAP JUNCTIONS FROM HOST CELLS TO TARGET CELLS AND A CELL-BASED DELIVERY SYSTEM FOR ANTISENSE OR SiRNA
10/11/2006	EP1709175A2 Hif oligonucleotide decoy molecules
10/11/2006	EP1709171A2 Cloning and characterization of 5' flanking regions of a human aggrecanase-1 gene
10/11/2006	EP1709084A1 Polypeptides for modulating binding of trp channel proteins and trp-associated proteins
10/11/2006	EP1708757A1 Use of human cord blood-derived pluripotent cells for the treatment of disease
10/11/2006	EP1708756A2 Treatment of mammals by sirna delivery into mammalian nerve cells
10/11/2006	EP1708732A2 Synthetic hla binding peptide analogues and uses thereof
10/11/2006	EP1708575A2 Improved modalities for the treatment of degenerative diseases of the retina
10/11/2006	EP1276505B1 Mixtures of triblock polyesterpolyethylene glycol copolymers
10/11/2006	EP1175436B1 Transiently immortalized cells for use in gene therapy
10/11/2006	EP1133311B1 INFLUENCING ANGIOGENESIS USING CD66a
10/11/2006	EP1070118B1 Modified adenovirus containing a fiber replacement protein
10/11/2006	EP0998307B1 METHOD FOR TREATING VASCULAR PROLIFERATIVE DISEASES WITH p27 AND FUSIONS THEREOF
10/11/2006	EP0914448B1 Lipid kinase
10/11/2006	EP0842209B1 Multiblock biodegradable hydrogels for use as controlled release agents for drugs and tissue treatment agents
10/11/2006	EP0751782B1 Use of a non-neutralizing antibody specific for the beta-subunit of luteinizing hormone for enhancing fertility
10/11/2006	EP0668777B1 Prostate-specific membrane antigen
10/11/2006	CN1845993A Interfering RNA duplex having blunt-ends and 3'-modifications
10/11/2006	CN1845987A Kidney derived stem cells and methods for their isolation, differentiation and use
10/11/2006	CN1844400A Recombinant plasmids containing B cell activation factor gene promoters with different lengths and their preparation method and application
10/11/2006	CN1844390A Duck B lymphocyte stimulating factor cDNA and its clone method and recombinant use
10/11/2006	CN1844387A Antisense oligonucleotide structure inhibiting Sirt1 gene expression and use thereof
10/11/2006	CN1844386A siRNA target gene sequence inhibiting gene expression of vascular endothelial growth factor
10/11/2006	CN1844170A Preparation for transgenic carrier of temperature-sensitive poly isopropyl acrylamide and poly arginine conjugate
10/11/2006	CN1843511A Use of ShRNA for suppressing telomere enzyme reverse transcriptase hTERT expression in antineoplastic action
10/11/2006	CN1843510A Preparation method and medicinal uses of Trichinella eelworm vaccine
10/11/2006	CN1843506A Medicine containing bacillus tubercle vaccine
10/10/2006	US7119187 Internal ribosome entry site of the labial gene for protein expression
10/10/2006	US7119186 Nucleotide sequences coding polypeptide for use in the treatment of spinocerebellar ataxia
10/10/2006	US7119185 nucleotide sequences that code serine/threonine protein kinase, used for analyzing or screening breast cancers; gene therapy
10/10/2006	US7119176 Antibodies specific to human prostacyclin synthase
10/10/2006	US7119174 AURORA-1/2 (AUR1/2) antibodies or fragments thereof; humanized monoclonal antibodies; hybridomas; immunoassay; for treatment of cancer and screening cell growth inhibitors
10/10/2006	US7119077 Multimeric forms of members of the steroid/thyroid superfamily of receptors with the ultraspiracle receptor
10/10/2006	US7118911 Full length isolation DNA codes transmembrane conductance controller proteins with mutants for gene expression
10/10/2006	US7118890 Antibodies to vertebrate delta proteins and fragments
10/10/2006	US7118888 Gene expression vaccine
10/10/2006	US7118885 Nucleic acid encoding vitamin D receptor related polypeptide
10/10/2006	US7118873 Polynucleotides encoding cellular transporters and methods of use thereof
10/10/2006	US7118755 Herpes viruses for immune modulation
10/10/2006	US7118749 Transferrin receptor genes
10/10/2006	US7118748 Method for promoting hematopoietic and mesenchymal cell proliferation and differentiation
10/10/2006	US7118744 Immunogenic compositions for induction of anti-tumor immunity
10/10/2006	US7118743 Bispecific molecules cross-linking ITIM and ITAM for therapy
10/10/2006	US7118738 Recombinant pox virus for immunization against MUC1 tumor-associated antigen
10/10/2006	CA2238277C Compositions and therapeutic methods using morphogenic proteins and stimulatory factors
10/10/2006	CA2175703C Alteration of sequence of a target molecule
10/05/2006	WO2006105279A2 Defective sindbis viral vectors
10/05/2006	WO2006105255A2 Cancer vaccines and therapeutic methods
10/05/2006	WO2006105204A2 Compositions and their uses directed to thymus and activation-regulated chemokine (tarc)
10/05/2006	WO2006105043A2 Janus dendrimers and dendrons
10/05/2006	WO2006104749A2 Compositions and methods for detecting compounds that treat a neurological disorder
10/05/2006	WO2006104615A2 Influenza nucleic acids, polypeptides, and uses thereof
10/05/2006	WO2006104289A1 Pharmaceutical composition for inhibition of tumor growth
10/05/2006	WO2006104099A1 RORα PROMOTING THE INDUCTION OF Bmal1 EXPRESSION
10/05/2006	WO2006103770A1 Method of regulating angiogenesis
10/05/2006	WO2006103343A1 Use of protein 2e9 for in vitro diagnosis of mycoplasma pneumoniae infections
10/05/2006	WO2006072809A8 Formulations that optimize intracellular concentration of nicotinamide adenine (nad+) and methods of use to protect cells and treat diseases and conditions
10/05/2006	WO2006066049A3 Humanized antibodies that recognize beta amyloid peptide
10/05/2006	WO2005116233A3 Composition and method of cancer treatment
10/05/2006	WO2005062942A3 Novel oligonucleotides and treating cardiac disorders by using the same
10/05/2006	WO2005014778A3 Dna vaccine expressing ha1 of equine-2 influenza virus
10/05/2006	WO2004044163A3 Methods for identifying risk of melanoma and treatments thereof
10/05/2006	WO2003106643A8 Novel polynucleotides encoding lamprey gnrh-iii
10/05/2006	US20060223990 Synthesis, deprotection, analysis & purification of RNA & ribozymes
10/05/2006	US20060223779 Method of screening for inhibitors of human Fatty Acid-CoA Ligase 4

1 ... 304 305 306 307 308 309 310 311 312 313 314 315 316 317 318 319 320 321 322 323 324 ... 870